Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Magnetically Mediated Hyperthermia: Current Status And Future Directions

P. Moroz, S. Jones, B. Gray
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The use of hyperthermia in the treatment of cancers is appealing because, as a physical therapy, hyperthermia would have far fewer restrictive side effects than chemotherapy and radiotherapy, and it could be used in combination with these therapies. However, the currently available modalities of hyperthermia are often limited by their inability to selectively target tumour tissue and, hence, they carry a high risk of collateral organ damage or they deposit heat in a very localized manner which can result in under-treatment of a tumour. Magnetically mediated hyperthermia (MMH) has the potential to address these shortcomings. MMH consists of the localization of magnetic particles or seeds within tumour tissue followed by exposure to an externally applied alternating magnetic field to cause them to heat. Since this concept was introduced (over 40 years ago), MMH has evolved into four general sub-classes: arterial embolization hyperthermia (AEH), direct injection hyperthermia (DIH), intracellular hyperthermia (IH) and interstitial implant hyperthermia (IIH). It is the purpose of this article to review these four sub-classes in terms of experimental or clinical results, advantages, limitations and current status.
This paper references
10.3109/02656739709046540
Anti-tumour effects of localized hyperthermia on an experimental bone tumour using an intramedullary nail.
M. Akagi (1997)
10.1016/0304-8853(93)91113-L
Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer
D. Chan (1993)
10.1148/RADIOLOGY.218.2.R01FE19570
Electromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice.
I. Hilger (2001)
Hyperthermic effects on the human metastatic liver: a TEM study.
V. Bertone (1997)
10.1016/0304-3835(94)03668-9
Induction of apoptotic cell DNA fragmentation in human cells after treatment with hyperthermia.
J. Fairbairn (1995)
Utilization of barium-impregnated ferromagnetic silicone in vascular occlusion.
M. Snyder (1975)
10.1016/0360-3016(92)90711-P
Treatment of malignant gliomas with interstitial irradiation and hyperthermia.
B. Stea (1992)
10.2307/3575874
Glass-ceramic-mediated, magnetic-field-induced localized hyperthermia: response of a murine mammary carcinoma.
A. Luderer (1983)
Presentation of a new magnetic ®eld therapy Magnetically mediated hyperthermia 283 system for the treatment of human solid tumours with magnetic ̄uid hyperthermia
A Jordan (2001)
10.1080/02656730110103519
Treatment of experimental rabbit liver tumours by selectively targeted hyperthermia
S. Jones (2002)
10.1111/J.1470-8744.1995.TB00339.X
Preparation and characteristics of magnetite‐labelled antibody with the use of poly(ethylene glycol) derivatives
M. Suzuki (1995)
10.1007/978-1-4757-6482-6
Scientific and clinical applications of magnetic carriers
U. Häfeli (1997)
The principle of induction heating for the thermal ablation of tissue in medical applications 2000; http://ablationtech.com/abinductheat.htm
RD Tucker (2000)
10.1016/0360-3016(95)02137-X
Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the radiation therapy oncology group
B. Emami (1993)
10.1007/978-3-642-80460-1_11
Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans.
M. D. de Vries (1998)
10.1002/(SICI)1097-4636(199822)43:2<210::AID-JBM16>3.0.CO;2-L
New ferromagnetic bone cement for local hyperthermia.
K. Takegami (1998)
10.3109/02656739309005047
Pattern of response to interstitial hyperthermia and brachytherapy for malignant intracranial tumour: a CT analysis.
T. Nakajima (1993)
10.1097/00000658-195710000-00007
Selective Inductive Heating of Lymph Nodes
R. Gilchrist (1957)
10.1089/END.1997.11.295
Thermal ablation of canine prostate using interstitial temperature self-regulating seeds: new treatment for prostate cancer.
J. Paulus (1997)
10.1038/251521A0
Combined hyperthermia and radiation suggest an alternative to heavy particle therapy for reduced oxygen enhancement ratios
J. Robinson (1974)
10.1016/0921-5093(94)90865-6
Temperature-sensitive amorphous magnetic flakes for intratissue hyperthermia
H. Matsuki (1994)
10.1111/j.1349-7006.1998.tb00586.x
Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.
M. Shinkai (1996)
Hyperthermia in cancer therapy: where are we today and where are we going?
Steeves Ra (1992)
The principle of induction heating for the thermal ablation of tissue in medical applications
R D Tucker (2000)
10.1016/0022-4804(83)90018-5
Internal radiotherapy for hepatic metastases II: The blood supply to hepatic metastases.
K. V. Stribley (1983)
Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors.
M. Mitsumori (1996)
10.3109/02656739709046543
Ferromagnetic hyperthermia: functional and histopathologic effects on normal rabbit ocular tissue.
T. Murray (1997)
Hyperthermia in cancer therapy: where are we today and where are we going?
R. Steeves (1992)
10.1016/S0960-7404(99)00007-9
The treatment of malignancy by hyperthermia.
C. Christophi (1998)
10.1007/978-3-642-82955-0_5
Hyperthermia and drugs.
R. Engelhardt (1987)
Preparation and characteristics of magnetite labelled antibody with the use of polyethylene glycol derivatives
M Suzuki (1995)
Acute liver failure after whole body hyperthermia treatment
S Hammerschmidt (1999)
10.1088/0022-3727/24/1/013
Measurement of the Neel relaxation of magnetic particles in the frequency range 1 kHz to 160 MHz
P. C. Fannin (1991)
10.2307/3578175
Hyperthermia induces apoptosis in thymocytes.
K. Sellins (1991)
Tumour blood ̄ow
P. Vaupel (2000)
10.3109/02656739409009351
Arrhenius relationships from the molecule and cell to the clinic.
W. Dewey (1994)
[Experimental study of embolo-hyperthermia for treatment of liver tumor--induction heating to ferromagnetic particles injected into tumor tissue].
M. Hase (1989)
10.1016/S0140-6736(95)90463-8
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma
J. Overgaard (1995)
10.3109/02656739609023688
Preoperative thermochemotherapy of oral cancer using magnetic induction hyperthermia (Implant Heating System: IHS).
I. Tohnai (1996)
10.1097/00000658-197311000-00021
Ferromagnetic Silicone Vascular Occlusion: A Technic for Selective Infarction of Tumors and Organs
J. A. Mosso (1973)
[Studies on liposomal ferromagnetic particles and a technique of high frequency inductive heating--in vivo studies of rabbits].
S. Suzuki (1990)
10.3109/02656738809029305
Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies.
T. Herman (1988)
10.1016/0022-4804(82)90026-9
Thermomagnetic surgery for cancer.
R. W. Rand (1982)
Targeting liver tumours with hyperthermia: Ferromagnetic embolization in a rabbit liver tumour model
P Moroz (2001)
10.1097/00000658-196506000-00008
Effects of Electromagnetic Heating on Internal Viscera: A Preliminary to the Treatment of Human Tumors
R. Gilchrist (1965)
10.1001/ARCHSURG.1959.04320090075011
Controlled Radio-Frequency Generator for Production of Localized Heat in Intact Animal: Mechanism and Construction
R. Medal (1959)
10.1080/02656730110095609
The effect of tumour size on ferromagnetic embolization hyperthermia in a rabbit liver tumour model
P. Moroz (2002)
10.1002/JSO.1106
Status of hyperthermia in the treatment of advanced liver cancer
P. Moroz (2001)
10.1002/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2
Selective heat sensitivity of cancer cells. Biochemical and clinical studies.
R. Cavaliere (1967)
10.1007/978-3-642-58813-6
Blood Perfusion and Microenvironment of Human Tumors
M. Molls (2000)
10.1016/0360-3016(95)00206-E
Thermoradiotherapy of intraocular tumors in an animal model: concurrent vs. sequential brachytherapy and ferromagnetic hyperthermia.
R. Steeves (1995)
10.1002/JSO.1118
Targeting liver tumors with hyperthermia: Ferromagnetic embolization in a rabbit liver tumor model
P. Moroz (2001)
10.1016/0002-9610(91)90088-U
Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases.
Ackerman Nb (1991)
10.1016/0360-3016(93)90427-W
Interstitial thermoradiotherapy with ferromagnetic implants for locally advanced and recurrent neoplasms.
C. Mack (1993)
Intracellular hyperthermia by ®xated submicron particle exciting in inductive ®eld of 500 kHz
K Tazawa (1988)
[Studies on selective embolo-hyperthermic therapy of tumors by using ferromagnetic particles].
M. Sako (1984)
10.1080/09553009114550441
The role of apoptosis in the response of cells and tumours to mild hyperthermia.
B. Harmon (1991)
The blood supply of neoplasms in the liver.
C. Breedis (1954)
10.1007/978-1-4757-6482-6_45
Physical Chemistry and in Vivo Tissue Heating Properties of Colloidal Magnetic Iron Oxides with Increased Power Absorption Rates
Daniel C. F. Chan (1997)
10.1007/BF00146877
Interstitial hyperthermia of malignant brain tumors by implant heating system: Clinical experience
T. Kobayashi (2004)
Experimental study of embolohyperthermia for the treatment of liver tumours by induction heating to ferromagnetic particles injected into tumour tissue
M Hase (1989)
10.1016/S0304-8853(00)01239-7
Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia
A. Jordan (2001)
Magnetic ̄uid hyperthermia
A Jordan (1997)
Hyperthermia: the development of management fees
L W Brady (1987)
E€ ects of magnetic ̄uid hyperthermia on C3H mammary carcinoma in vivo
A Jordan (1997)
10.5694/j.1326-5377.1990.tb120955.x
Hyperthermia in cancer therapy: current status
R. L. Anderson (1990)
[Experimental study of ferromagnetic induction heating combined with hepatic arterial embolization for treatment of liver tumors].
M. Hase (1990)
10.3109/02656739709023559
Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
A. Jordan (1997)
Hyperthermia and drugs. Recent Re
R Engelhardt (1987)
10.1007/978-3-642-81080-0
Selective Heat Sensitivity of Cancer Cells
A. Rossi-Fanelli (1977)
10.1016/0306-9877(79)90063-X
Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations.
R. Gordon (1979)
[Hyperthermia of metastatic brain tumor with implant heating system: a preliminary clinical results].
Y. Kida (1990)
10.1002/BJS.1800760607
Vascularization of small liver metastases
S. Archer (1989)
10.1016/0360-3016(92)90945-E
Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis.
B. Stea (1994)
Hyperthermia: the development of management
LW Brady (1987)
Treatment of prostate cancer by thermal ablation using interstitial temperature self-regulating seeds. Poster Presentation
S A Loening (1997)
10.3109/02656739409012371
Development of intra-arterial hyperthermia using a dextran-magnetite complex.
M. Mitsumori (1994)
10.1016/S0304-8853(98)00558-7
Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro
A. Jordan (1999)
10.3109/02656739309061478
Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia.
A. Jordan (1993)
Selective radiofrequency heating of ferrosilicone occluded tissue: a preliminary report.
R. W. Rand (1976)
10.1109/TBME.1971.4502810
The RF thermoseed--a thermally self-regulating implant for the production of brain lesions.
C. Burton (1971)
Treatment of prostate cancer by thermal ablation using interstitial temperature self-regulating seeds
SA Loening (1997)
10.1097/00004424-200003000-00003
Effects of magnetic thermoablation in muscle tissue using iron oxide particles: an in vitro study.
I. Hilger (2000)
10.1252/JCEJ.34.66
Preparation of Tumor-Specific Magnetoliposomes and Their Application for Hyperthermia
B. Le (2001)
Controlled radiofrequency generator for production of localized heat in intact animal
R Medal (1959)
Hyperthermia and induced apoptosis in thymocytes
KS Sellins (1991)
Ferromagnetic silicone vascular occlusion
JA Mosso (1973)
10.1088/0031-9155/29/5/001
Hysteresis heating for the treatment of tumours.
N. Borrelli (1984)
10.1016/0960-7404(94)90005-1
Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy.
L. Hafström (1994)
10.1016/0360-3016(89)90470-7
The current and potential role of hyperthermia in radiotherapy.
J. Overgaard (1989)
10.3109/02656739609027678
Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro.
A. Jordan (1996)
10.1001/ARCHOPHT.1996.01100140576008
Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma.
T. Murray (1996)
10.3892/IJO.16.6.1153
Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats.
T. Minamimura (2000)
E€ ects of electromagnetic heating on internal viscera: a preliminary to the treatment of human tumours
RK Gilchrist (1965)



This paper is referenced by
10.3390/ma3031981
End-Grafted Polymer Chains onto Inorganic Nano-Objects
D. S. Achilleos (2010)
Influence of techno-science on society from a hermeneutic perspective
F. J. Carrera (2016)
Embolización de metástasis hepáticas de adenocarcinoma de colon con magnetofluido: caracterización por imagen del modelo experimental
J. E. Uraga (2009)
10.1039/B402025A
Magnetic nanoparticle design for medical diagnosis and therapy
S. Mornet (2004)
10.1111/j.1349-7006.2003.tb01527.x
Selective hyperthermia using magnetoliposomes to target cervical lymph node metastasis in a rabbit tongue tumor model
S. Hamaguchi (2003)
10.1021/ar200090c
Monodisperse magnetic nanoparticles for theranostic applications.
Don N. Ho (2011)
10.1186/1477-3155-9-13
Porphyrin-magnetite nanoconjugates for biological imaging
Małgorzata Nowostawska (2011)
10.1002/9783527610419.NTLS0169
Core–Shell Magnetic Nanomaterials in Medical Diagnosis and Therapy
M. Melancon (2011)
10.1080/02656730902803118
Enhancement in treatment planning for magnetic nanoparticle hyperthermia: Optimization of the heat absorption pattern
M. Salloum (2009)
10.1021/cr200359p
Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy.
J. Yao (2014)
10.1002/9783527694396.CH13
Magnetic Iron Oxide Nanoparticles: Bioapplications and Potential Toxicity
Hongying Su (2016)
10.1063/1.4992021
Magnetic induction of hyperthermia by a modified self-learning fuzzy temperature controller.
Wei-Cheng Wang (2017)
Microparticules magnétiques thérapeutiques pour la chimio-embolisation ciblée du foie
Pierre Pouponneau (2011)
Hyperthermia Treatment onTumorSubject to External EM Field
Z. Deng (2006)
10.1007/S10550-006-0072-3
Nanomagnetic medical sensors and treatment methodologies
Q. Pankhurst (2006)
10.1039/C6RA23470D
Synthesis of amine-polyglycidol functionalised Fe3O4@SiO2 nanocomposites for magnetic hyperthermia, pH-responsive drug delivery, and bioimaging applications
M. S. Moorthy (2016)
10.1002/9781119127420.CH29
Magnetic Nanoparticle Hyperthermia in Cancer Treatment: History, Mechanism, Imaging‐Assisted Protocol Design, and Challenges
A. LeBrun (2018)
10.1007/978-981-10-3563-0_1
SPIONs as Nano-Theranostics Agents
A. Zarepour (2017)
10.1007/978-0-387-76554-9_13
Multifunctional Magnetic Nanosystems for Tumor Imaging, Targeted Delivery, and Thermal Medicine
D. Nagesha (2008)
10.1007/978-1-62703-475-3_4
Toxicity of novel nanosized formulations used in medicine.
A. El-Ansary (2013)
10.1007/s11051-012-1128-6
More efficient NIR photothermal therapeutic effect from intracellular heating modality than extracellular heating modality: an in vitro study
W. Zhou (2012)
10.1016/J.JMMM.2009.02.077
Magnetic properties and heating effect in bacterial magnetic nanoparticles
M. Timko (2009)
10.17169/REFUBIUM-12611
DNA-Strangbrüche in humanen HL-60 Promyelozytenleukämiezellen zur Einschätzung biologischer Wirkungen nach Exposition mit hochfrequenten elektromagnetischen Feldern (2450 MHz)
Leila Violette Khubnazar (2006)
10.1039/C7TB00922D
Tailoring La1-xSrxMnO3 (0.25 ≤x≤ 0.35) nanoparticles for self-regulating magnetic hyperthermia therapy: an in vivo study.
M. Soleymani (2017)
10.1002/adma.201405036
Magnetic vortex nanorings: a new class of hyperthermia agent for highly efficient in vivo regression of tumors.
X. Liu (2015)
10.1155/2014/359316
Bacteria in Nanoparticle Synthesis: Current Status and Future Prospects
S. Iravani (2014)
10.1016/J.COMPOSITESB.2014.12.003
New nanocomposite based on poly(lactic-co-glycolic acid) copolymer and magnetite. Synthesis and characterization
N. Tudorachi (2015)
10.2147/IJN.S50373
Targeted hyperthermia after selective embolization with ferromagnetic nanoparticles in a VX2 rabbit liver tumor model
Hong-liang Sun (2013)
10.2217/nnm.14.106
Antitumor immunity by magnetic nanoparticle-mediated hyperthermia.
T. Kobayashi (2014)
10.1007/978-90-481-9704-0_21
Induced Hyperthermia in the Treatment of Cancer
B. Hildebrandt (2011)
10.1016/J.JMMM.2009.05.043
Critical RF losses in fine particles of La1−xAgyMnO3+δ: Prospects for temperature-controlled hyperthermia
V. A. Atsarkin (2009)
10.1088/0022-3727/36/13/201
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
See more
Semantic Scholar Logo Some data provided by SemanticScholar